Close Menu

NEW YORK — Pharmacogenetic test results might not lead patients to avoid certain helpful treatments as feared, a new clinical trial focusing on statins has found.

Pharmacogenetic testing enables patients to learn whether they harbor any genetic variants that could affect their response to particular drugs, with an eye toward selecting more effective therapies. But there are also concerns that positive test results could lead patients to avoid drugs for their possible adverse effects and shy away from treatments from which they may still benefit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.